biosmilars

After long road to approval, Teva and Alvotech believe their Humira biosimilar Simlandi may have an edge
Fierce Pharma
Sun, 02/25/24 - 08:57 pm
Teva Pharmaceutical
Alvotech
AbbVie
Humira
biosmilars
A Key Novartis Drug Could Be Delayed — Why This Stock Is Cheering
Investors Business Daily
Sat, 10/5/19 - 02:17 pm
Coherus Biosciences
Novartis
Udenyca
Neulasta
biosmilars